openPR Logo
Press release

Suppositories Market to Reach USD 3.3 Billion by 2036, Driven by Non-Oral Drug Delivery Demand and OTC Expansion

06-05-2026 08:24 AM CET | Health & Medicine

Press release from: Fact.MR

Suppositories Market

Suppositories Market

According to the latest analysis by Fact.MR, the global suppositories market is steadily expanding as healthcare systems increase reliance on non-oral dosage forms for patients with swallowing difficulties and specialized treatment needs. Rising over-the-counter (OTC) availability, aging populations, and hospital-based care demand are reinforcing growth across both clinical and retail channels.

Get detailed market forecasts, competitive benchmarking, and pricing trends: https://www.factmr.com/connectus/sample?flag=S&rep_id=8105

Executive Summary & Stakeholder Insights

• Market valued at USD 1.8 billion (2025), increasing to USD 1.9 billion (2026) and projected to reach USD 3.3 billion by 2036
• CAGR stands at 5.7% (2026-2036)
• Rectal suppositories lead with 68.0% share (2026) due to bowel care and non-oral administration needs
• Lipophilic base formulations dominate with 59.0% share (2026) supporting melt-based drug release
• Semi-solid forms hold 74.0% share (2026) ensuring stability and controlled softening
• OTC products account for 56.0% share (2026) driven by retail pharmacy accessibility
• Hemorrhoids application leads with 34.0% share (2026) due to local treatment demand
• Core demand drivers:
o Increasing need for non-oral drug delivery in hospitals
o Rising demand for constipation relief and bowel care products
o Expansion of OTC availability through retail pharmacies
• Market evolution:
o Transition toward patient-centric and easy-to-administer dosage forms
o Growing emphasis on formulation stability and storage control
o Increasing demand for clear labeling and safe-use instructions

Comparative Data Insights

Global suppositories market grows at 5.7% CAGR (2026-2036) driven by non-oral drug delivery demand
United States records 5.1% CAGR supported by hospital care and OTC laxative use
Japan achieves 5.0% CAGR driven by aging population and patient care needs
South Korea grows at 4.9% CAGR due to hospital pharmacy expansion
Germany expands at 4.7% CAGR supported by pharmaceutical manufacturing and clinical demand
United Kingdom records 4.6% CAGR driven by constipation care and palliative treatment use

Competitive Landscape & Entity Mapping

• Pfizer Inc. (18-22%)
o Strong in global pharmaceutical distribution and specialty formulations
• Novartis AG (15-19%)
o Focuses on advanced drug formulations and global healthcare reach
• Bayer AG (12-16%)
o Expands in consumer health and OTC suppository products
• Aenova Group (9-13%)
o Specializes in contract manufacturing for dosage forms
• LGM Pharma (7-11%)
o Provides suppository development and manufacturing services
• Strategic focus:
o Enhancing formulation stability and drug release systems
o Expanding OTC distribution and pharmacy partnerships
o Strengthening contract manufacturing capabilities

Segment-Wise Performance

By Product Type

Rectal Suppositories - 68.0% Market Share (2026)
• Dominates due to bowel care and non-oral medication demand
• Widely used in hospital and home care settings

By Base Type

Lipophilic Bases - 59.0% Market Share (2026)
• Leads due to melt-based drug release mechanism
• Preferred for rectal drug delivery systems

By Form

Semi-Solid Forms - 74.0% Market Share (2026)
• Dominates due to shape stability and controlled softening
• Ensures consistent dosage delivery

By Availability

Over-the-Counter (OTC) - 56.0% Market Share (2026)
• Leads due to retail pharmacy accessibility for constipation relief
• Supports self-care and short-term treatment

By Application

Hemorrhoids - 34.0% Market Share (2026)
• Dominates due to localized treatment benefits and symptom relief

Access the Full Data-Driven Market Study: https://www.factmr.com/report/suppositories-market

Direct Q& - Suppositories Market

What is the projected size of the suppositories market by 2036?
The market will reach USD 3.3 billion by 2036. Growth is driven by non-oral drug demand.

What is the CAGR of the suppositories market?
The market grows at a CAGR of 5.7% from 2026 to 2036. Demand remains steady across healthcare.

Which product type dominates the suppositories market?
Rectal suppositories lead with 68.0% share. Bowel care drives demand.

Which segment drives OTC demand in the suppositories market?
OTC products lead with 56.0% share. Retail accessibility supports growth.

Which application segment dominates the suppositories market?
Hemorrhoids lead with 34.0% share. Local treatment drives usage.

Browse the Most In-Demand Healthcare Market Studies: https://www.factmr.com/industry/healthcare

Unlock 360° insights for strategic decision making and investment planning: https://www.factmr.com/connectus/sample?flag=S&rep_id=8105

To View Our Related Report:

Tracheal Stents Market: https://www.factmr.com/report/tracheal-stents-market
3D Medical Imaging Devices Market: https://www.factmr.com/report/3d-medical-imaging-devices-market
Clinical Drainage Supplies Market: https://www.factmr.com/report/clinical-drainage-supplies-market
Centesis Catheters Market: https://www.factmr.com/report/centesis-catheters-market

- Contact Us -
11140 Rockville Pike, Suite 400, Rockville,
MD 20852, United States
Tel: +1 (628) 251-1583 | sales@factmr.com

Fact.MR is a global market research and consulting firm, trusted by Fortune 500 companies and emerging businesses for reliable insights and strategic intelligence. With a presence across the U.S., UK, India, and Dubai, we deliver data-driven research and tailored consulting solutions across 30+ industries and 1,000+ markets. Backed by deep expertise and advanced analytics, Fact.MR helps organizations uncover opportunities, reduce risks, and make informed decisions for sustainable growth.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Suppositories Market to Reach USD 3.3 Billion by 2036, Driven by Non-Oral Drug Delivery Demand and OTC Expansion here

News-ID: 4539229 • Views:

More Releases from Fact.MR

Prebiotic Scalp Mists Market to Reach USD 1,150 Million by 2036, Growing at 10.0% CAGR as Scalp-First Beauty Routines Redefine Premium Haircare
07-16-2026 | Health & Medicine
Fact.MR
Prebiotic Scalp Mists Market to Reach USD 1,150 Million by 2036, Growing at 10.0 …
Inulin-Based Mists Lead with 34.0% Share, Prestige Beauty Channels Hold 36.0%, South Korea Emerges as Fastest-Growing Market at 12.4% CAGR The global Prebiotic Scalp Mists Market is poised for substantial expansion as scalp-first beauty routines, microbiome-friendly haircare solutions, and leave-in treatment formats gain mainstream acceptance among consumers. According to the latest Fact.MR analysis, the market is projected to grow from USD 445.0 million in 2026 to USD 1,150 million by 2036,
Peptide Hair Tonics Market to Reach USD 718 Million by 2036, Expanding at 8.7% CAGR as Premium Scalp Care and Peptide Innovation Reshape Hair Wellness
07-16-2026 | Health & Medicine
Fact.MR
Peptide Hair Tonics Market to Reach USD 718 Million by 2036, Expanding at 8.7% C …
Premium Peptide Hair Tonics Demand Accelerates; Copper Peptides Hold 36.0% Share, Prestige Beauty Channel Leads with 39.0%, United States Forecast to Grow at 9.2% CAGR The global Peptide Hair Tonics Market is entering a new phase of growth as consumers increasingly adopt science-backed scalp treatment solutions designed to improve hair density, scalp health, and overall hair quality. According to the latest market analysis by Fact.MR, the market is expected to grow
LED Scalp Brushes Market to Reach USD 2.6 Billion by 2036 at 10.0% CAGR as Scalp-First Haircare and At-Home Light Therapy Redefine Premium Beauty Devices
07-16-2026 | Health & Medicine
Fact.MR
LED Scalp Brushes Market to Reach USD 2.6 Billion by 2036 at 10.0% CAGR as Scalp …
Red LED Technology Commands 42.0% Market Share in 2026, Density-Focused Applications Lead at 34.0%, While India Emerges as the Fastest-Growing Market with 12.4% CAGR The global LED Scalp Brushes Market is forecast to grow from USD 1.0 billion in 2026 to USD 2.6 billion by 2036, registering a 10.0% CAGR during the 2026-2036 forecast period. The market surpassed USD 0.9 billion in 2025, highlighting growing consumer demand for device-led scalp care
Grip Strength Trainers Market to Reach USD 720.0 Million by 2036 at 20.1% CAGR as Home Fitness, Climbing, and Strength Training Drive Global Demand
Grip Strength Trainers Market to Reach USD 720.0 Million by 2036 at 20.1% CAGR a …
Online Retail to Command 58.0% Market Share in 2026, Individual Users Lead with 54.0%, While the United States Emerges as the Fastest-Growing Major Market at 21.8% CAGR The global Grip Strength Trainers Market is poised for significant expansion, with industry revenue projected to increase from USD 115.0 million in 2026 to USD 720.0 million by 2036, registering a robust 20.1% CAGR during the 2026-2036 forecast period. The market had already surpassed

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to